company background image
500126 logo

Procter & Gamble Health BSE:500126 Stock Report

Last Price

₹5.84k

Market Cap

₹96.9b

7D

5.2%

1Y

15.4%

Updated

13 Jun, 2025

Data

Company Financials +

Procter & Gamble Health Limited

BSE:500126 Stock Report

Market Cap: ₹96.9b

Procter & Gamble Health (500126) Stock Overview

Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. More details

500126 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends4/6

500126 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Procter & Gamble Health Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Procter & Gamble Health
Historical stock prices
Current Share Price₹5,839.05
52 Week High₹6,107.55
52 Week Low₹4,905.65
Beta0.42
1 Month Change11.53%
3 Month Change11.44%
1 Year Change15.39%
3 Year Change46.27%
5 Year Change47.70%
Change since IPO141,969.34%

Recent News & Updates

Recent updates

Shareholder Returns

500126IN PharmaceuticalsIN Market
7D5.2%1.7%0.5%
1Y15.4%13.7%1.0%

Return vs Industry: 500126 exceeded the Indian Pharmaceuticals industry which returned 13.7% over the past year.

Return vs Market: 500126 exceeded the Indian Market which returned 1% over the past year.

Price Volatility

Is 500126's price volatile compared to industry and market?
500126 volatility
500126 Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement6.4%
Market Average Movement6.6%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market4.4%

Stable Share Price: 500126 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 500126's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19671,336Milind Thattewww.pghealthindia.com

Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands.

Procter & Gamble Health Limited Fundamentals Summary

How do Procter & Gamble Health's earnings and revenue compare to its market cap?
500126 fundamental statistics
Market cap₹96.92b
Earnings (TTM)₹2.51b
Revenue (TTM)₹12.18b
38.6x
P/E Ratio
8.0x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
500126 income statement (TTM)
Revenue₹12.18b
Cost of Revenue₹3.54b
Gross Profit₹8.64b
Other Expenses₹6.13b
Earnings₹2.51b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)151.32
Gross Margin70.97%
Net Profit Margin20.62%
Debt/Equity Ratio0%

How did 500126 perform over the long term?

See historical performance and comparison

Dividends

2.1%
Current Dividend Yield
122%
Payout Ratio

Does 500126 pay a reliable dividends?

See 500126 dividend history and benchmarks
When do you need to buy 500126 by to receive an upcoming dividend?
Procter & Gamble Health dividend dates
Ex Dividend DateAug 22 2025
Dividend Pay DateSep 25 2025
Days until Ex dividend69 days
Days until Dividend pay date103 days

Does 500126 pay a reliable dividends?

See 500126 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/13 19:27
End of Day Share Price 2025/06/13 00:00
Earnings2025/03/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Procter & Gamble Health Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Ranjit KapadiaCentrum Broking Limited
Anil BurraFirstCall Research